Found 30 articles for: "hidradenitis suppurativa"
Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics
August 2026 | Volume 25 | Issue 8 | Editorials | e75 | Copyright © August 2026
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape
August 2026 | Volume 25 | Issue 8 | Features | 765 | Copyright © August 2026
A Decade of Hair Prosthetic Injuries: A Review of United States Emergency Department Cases (2013-2022)
March 2026 | Volume 25 | Issue 3 | Features | 277 | Copyright © March 2026
Treatment Strategy for Refractory Dissecting Cellulitis of the Scalp Using Bimekizumab, Isotretinoin, and Oral Antibiotics
March 2026 | Volume 25 | Issue 3 | Case Reports | 275 | Copyright © March 2026
Dissecting cellulitis of the scalp (DCS) is a chronic inflammatory disorder of the scalp that manifests as inflamed nodules and abscesses, with subsequent patchy, scarring hair loss. While its ex...
Read MoreGLP-1 Receptor Agonists in Overweight and Obese Patients With Hidradenitis Suppurativa
February 2026 | Volume 25 | Issue 2 | Features | 178 | Copyright © February 2026
Nourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa
November 2025 | Volume 24 | Issue 11 | Original Article | 1103 | Copyright © November 2025
Hidradenitis suppurativa (HS) is a complex skin condition influenced by both genetic and environmental factors. Increasing evidence points to diet as a key contributor to disease severity through...
Read MoreGlucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study
September 2025 | Volume 24 | Issue 9 | Original Article | 869 | Copyright © September 2025
Background: Hidradenitis suppurativa is a chronic inflammatory skin condition frequently associated with type 2 diabetes mellitus and obesity. Glucagon-like peptide-1 receptor ag...
Read MoreChatGPT Improves Readability of Patient Education Materials for Hidradenitis Suppurativa and Psoriasis
August 2025 | Volume 24 | Issue 8 | Features | 828 | Copyright © August 2025
Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa
June 2025 | Volume 24 | Issue 6 | Editorials | e45 | Copyright © June 2025
The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa
April 2025 | Volume 24 | Issue 4 | Original Article | 381 | Copyright © April 2025
Background: Hidradenitis suppurativa (HS) is a chronic autoinflammatory condition notable for a high psychosocial burden on patients. This burden is theorized to be linked to pat...
Read MoreExploring the Therapeutic Potential of GLP-1 Agonists in Hidradenitis Suppurativa
April 2025 | Volume 24 | Issue 4 | Editorials | 422 | Copyright © April 2025
Hidradenitis Suppurativa Found Associated With Cytokine Storm
May 2024 | Volume 23 | Issue 5 | Editorials | e134 | Copyright © May 2024
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that generates multiple cytokines. Here, we present an example of the cytokines forming a cytokine sto...
Read MoreComplementary and Alternative Medicine for Hidradenitis Suppurativa Discussed on TikTok: A Cross-Sectional Analysis
March 2024 | Volume 23 | Issue 3 | Editorials | e93 | Copyright © March 2024
Background: Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively affects patient quality of life, and conventional treatments are variabl...
Read MoreA New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers
February 2024 | Volume 23 | Issue 2 | Features | 105 | Copyright © February 2024
Background: Hidradenitis suppurativa (HS) patients tend to experience diagnosis delay, misdiagnosis, and embarrassment due to their condition. To address these issues, the Intern...
Read MoreDapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series
November 2023 | Volume 22 | Issue 11 | Features | e12 | Copyright © November 2023
Background: Management of hidradenitis suppurativa (HS) is challenging since no single treatment provides consistently effective results, leaving patients with frequent relapses....
Read MoreA Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development
October 2023 | Volume 22 | Issue 10 | Original Article | 1021 | Copyright © October 2023
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses leading to subsequent scarring and tunnel form...
Read MoreHormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
August 2023 | Volume 22 | Issue 8 | Original Article | 785 | Copyright © August 2023
Background: Hidradenitis suppurativa (HS) is an inflammatory skin condition characterized by recurrent abscesses, nodules, and sinus tracts. Hormones are thought to play an impor...
Read MoreRacial Disparities in the Treatment of Hidradenitis Suppurativa: An Analysis of Data from the National Ambulatory Medical Care Survey
July 2023 | Volume 22 | Issue 7 | Features | 692 | Copyright © July 2023
Hidradenitis suppurativa (HS) is a painful, disfiguring, chronic inflammatory disease affecting the axillary, inframammary, and groin regions. Black Americans are disproportionately affected by H...
Read MoreBarriers to Dermatologic Care and Use of Internet Sources in Hidradenitis Suppurativa
July 2023 | Volume 22 | Issue 7 | Editorials | 710 | Copyright © July 2023
Poondru S, Scott K, Riley JM. Barriers to dermatologic care and use of internet sources in hidradenitis suppurativa. J Drugs Dermatol. 2023;22(7):710-711. doi:10.36849/JDD.7355....
Read MoreWomen of Childbearing Age With Hidradenitis Suppurativa Frequently Prescribed Medications With Pregnancy Risk
July 2023 | Volume 22 | Issue 7 | Editorials | 706 | Copyright © July 2023
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
